168 related articles for article (PubMed ID: 15546488)
1. Treatment decision-making and the form of risk communication: results of a factorial survey.
Hembroff LA; Holmes-Rovner M; Wills CE
BMC Med Inform Decis Mak; 2004 Nov; 4():20. PubMed ID: 15546488
[TBL] [Abstract][Full Text] [Related]
2. Different ways to describe the benefits of risk-reducing treatments: a randomized trial.
Halvorsen PA; Selmer R; Kristiansen IS
Ann Intern Med; 2007 Jun; 146(12):848-56. PubMed ID: 17577004
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant chemotherapy for breast cancer: how presentation of recurrence risk influences decision-making.
Chao C; Studts JL; Abell T; Hadley T; Roetzer L; Dineen S; Lorenz D; YoussefAgha A; McMasters KM
J Clin Oncol; 2003 Dec; 21(23):4299-305. PubMed ID: 14581440
[TBL] [Abstract][Full Text] [Related]
4. Presenting health risk information in different formats: the effect on participants' cognitive and emotional evaluation and decisions.
Timmermans DR; Ockhuysen-Vermey CF; Henneman L
Patient Educ Couns; 2008 Dec; 73(3):443-7. PubMed ID: 18722073
[TBL] [Abstract][Full Text] [Related]
5. Communicating the benefits of chronic preventive therapy: does the format of efficacy data determine patients' acceptance of treatment?
Hux JE; Naylor CD
Med Decis Making; 1995; 15(2):152-7. PubMed ID: 7783576
[TBL] [Abstract][Full Text] [Related]
6. How making a risk estimate can change the feel of that risk: shifting attitudes toward breast cancer risk in a general public survey.
Fagerlin A; Zikmund-Fisher BJ; Ubel PA
Patient Educ Couns; 2005 Jun; 57(3):294-9. PubMed ID: 15893211
[TBL] [Abstract][Full Text] [Related]
7. The effects of absolute risks, relative risks, frequencies, and probabilities on decision quality.
Covey J
J Health Commun; 2011 Aug; 16(7):788-801. PubMed ID: 21614719
[TBL] [Abstract][Full Text] [Related]
8. Women's willingness to accept perceived risks for vasomotor symptom relief.
Johnson FR; Ozdemir S; Hauber B; Kauf TL
J Womens Health (Larchmt); 2007 Sep; 16(7):1028-40. PubMed ID: 17903080
[TBL] [Abstract][Full Text] [Related]
9. Risk and Rationality in Adolescent Decision Making: Implications for Theory, Practice, and Public Policy.
Reyna VF; Farley F
Psychol Sci Public Interest; 2006 Sep; 7(1):1-44. PubMed ID: 26158695
[TBL] [Abstract][Full Text] [Related]
10. Reducing the influence of anecdotal reasoning on people's health care decisions: is a picture worth a thousand statistics?
Fagerlin A; Wang C; Ubel PA
Med Decis Making; 2005; 25(4):398-405. PubMed ID: 16061891
[TBL] [Abstract][Full Text] [Related]
11. Treatment effect expressed as the novel Delay of Event measure is associated with high willingness to initiate preventive treatment - A randomized survey experiment comparing effect measures.
Berglund E; Westerling R; Sundström J; Lytsy P
Patient Educ Couns; 2016 Dec; 99(12):2005-2011. PubMed ID: 27499030
[TBL] [Abstract][Full Text] [Related]
12. Elective orthognathic treatment decision making: a survey of patient reasons and experiences.
Stirling J; Latchford G; Morris DO; Kindelan J; Spencer RJ; Bekker HL
J Orthod; 2007 Jun; 34(2):113-27; discussion 111. PubMed ID: 17545299
[TBL] [Abstract][Full Text] [Related]
13. Randomized trial of presenting absolute v. relative risk reduction in the elicitation of patient values for heart disease prevention with conjoint analysis.
Griffith JM; Lewis CL; Hawley S; Sheridan SL; Pignone MP
Med Decis Making; 2009; 29(2):167-74. PubMed ID: 19279298
[TBL] [Abstract][Full Text] [Related]
14. An informed decision? Breast cancer patients and their knowledge about treatment.
Fagerlin A; Lakhani I; Lantz PM; Janz NK; Morrow M; Schwartz K; Deapen D; Salem B; Liu L; Katz SJ
Patient Educ Couns; 2006 Dec; 64(1-3):303-12. PubMed ID: 16860523
[TBL] [Abstract][Full Text] [Related]
15. Patients' willingness to use a pharmacist-provided medication management service: the influence of outcome expectancies and communication efficacy.
Carter SR; Moles R; White L; Chen TF
Res Social Adm Pharm; 2012; 8(6):487-98. PubMed ID: 22381916
[TBL] [Abstract][Full Text] [Related]
16. Presenting Numeric Information with Percentages and Descriptive Risk Labels: A Randomized Trial.
Sinayev A; Peters E; Tusler M; Fraenkel L
Med Decis Making; 2015 Nov; 35(8):937-47. PubMed ID: 25952743
[TBL] [Abstract][Full Text] [Related]
17. Length of time periods in treatment effect descriptions and willingness to initiate preventive therapy: a randomised survey experiment.
Berglund E; Westerling R; Sundström J; Lytsy P
BMC Med Inform Decis Mak; 2018 Nov; 18(1):106. PubMed ID: 30458757
[TBL] [Abstract][Full Text] [Related]
18. Expressing medicine side effects: assessing the effectiveness of absolute risk, relative risk, and number needed to harm, and the provision of baseline risk information.
Berry DC; Knapp P; Raynor T
Patient Educ Couns; 2006 Oct; 63(1-2):89-96. PubMed ID: 16242904
[TBL] [Abstract][Full Text] [Related]
19. Risk management frameworks for human health and environmental risks.
Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
[TBL] [Abstract][Full Text] [Related]
20. The impact of risk on preference values: implications for evaluations of postmenopausal osteoporosis therapy.
Coyle D; Wells G; Graham I; Lee KM; Peterson JE; Papadimitropoulos E
Value Health; 2001; 4(5):385-91. PubMed ID: 11705129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
